Aug 16, 2020 · Under objective 2 of the Eradication and Endgame Plan, at least one dose of inactivated poliomyelitis vaccine (IPV) should be introduced into all routine immunization …

Mar 1, 2024 · The novel oral polio vaccine (nOPV2) is currently in the wider use roll-out phase under WHO Emergency Use Listing (EUL) for the control of type 2 circulating vaccine-derived …

poliovirus cases by 99.9% since 1988. The vaccine is very safe and interrupts person-to-person spread of polio. However, on rare occasions, in under-immunised populations, the live …

Mar 14, 2018 · OPV is safe and effective. However, in extremely rare cases (at a rate of approximately 1 in 2.7 million doses) the weakened vaccine-virus in OPV can cause vaccine …

Both OPV and IPV may be co-administered with other infant vaccines. l For infants starting the routine immunization schedule late (age >3 months) the IPV dose should be administered at …

A second type of polio vaccine, the oral polio vaccine (OPV) was developed by physician and microbiologist Albert Sabin. Sabin’s vaccine was live-attenuated (using the virus in weakened …

This mechanism, combined with the ease of oral administration and the very low cost of the vaccine, have made it the vaccine of choice for the global eradication programme. Although …

Heymann DL et al (1987) provided proof of the considerable herd immunity effects of OPV in a study in Cameroon. Incidence of paralytic polio decreased by 85%, although only 35% of …

Oral polio vaccine is the most heat sensitive of all vaccines used in the Expamded Programme on Immunization (EPI). Storage and transport have to comply with good cold chain practices. …

Mar 25, 2016 · The recommendations from the 2014 WHO position paper on the use of polio vaccine, in particular on the addition of at least one dose of IPV for countries using exclusively …